|
Deadline: 20 March 2003
1. PREPARATION: The abstract should be a brief summary of the paper and should include an introductory sentence stating its purpose. A brief description of the work involved and a statement of any conclusions
is to be drawn from the work should be included. The results will be discussed.
2. RESPONSIBILITY: Authors have full responsibility for any statements submitted. Authors are also responsible for proofreading the typed abstract. Authors must disclose and explain any potential conflicts of
interest in a separate letter enclosed with the abstract.
3. CHANGES: Once abstracts have been submitted to the Workshop Organizing Committee, changes will not be permitted.
4. TITLE: Capitalize all letters. Keep brief, indicating the nature of the investigation.
5. AUTHORS: List last name, then state author's names and institutional affiliations. If no institution is involved, list city and state.
6. TEXT: Type in lower case letters. Do not skip a line between title and author and between author and text. Indent beginning paragraph three spaces. The text must be a single paragraph. Use only very common
abbreviations. Non-proprietary (generic) names are required the first time a drug is mentioned and are to be written in lower case letters.
7. SUBMISSION REQUIREMENTS: Abstract must be submitted in one or both of the following forms, which must fit in the box provided:
A. Typewritten abstract plus three (3) photocopies, and if available,
B. Abstract on 3.5" floppy disk. The file should be formatted in Microsoft Word for Windows. Disk must be labeled with author's name, title of paper, and word processing program used including version number.
Provide a printout of the abstract plus three (3) copies of that exactly match the disk file. File names must clearly indicate the contents of each file.
Copy of Abstract Form (Requires Acrobat Reader to view & print)
|
